By Allison Prang 
 

Edwards Lifesciences Corp. affirmed its outlook for 2021.

The medical-device company said it still expects adjusted earnings to be between $2 and $2.20 a share. It also still expects between $4.9 billion and $5.3 billion in sales. According to FactSet, analysts are expecting $2.14 in adjusted earnings.

Edwards also said it expects between $1.1 billion and $1.2 billion in sales this quarter. For adjusted earnings, it is expecting between 43 cents a share and 50 cents a share. Analysts are expecting 50 cents a share in adjusted earnings.

 

Write to Allison Prang at allison.prang@wsj.com

 

(END) Dow Jones Newswires

January 27, 2021 16:59 ET (21:59 GMT)

Copyright (c) 2021 Dow Jones & Company, Inc.
Edwards Lifesciences (NYSE:EW)
Historical Stock Chart
From Mar 2024 to Apr 2024 Click Here for more Edwards Lifesciences Charts.
Edwards Lifesciences (NYSE:EW)
Historical Stock Chart
From Apr 2023 to Apr 2024 Click Here for more Edwards Lifesciences Charts.